Clinical Trial Update: High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating high-dose pemetrexed for brain metastases from lung adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Lung Adenocarcinoma

Drugs mentioned

• Alimta (pemetrexed)

Snippet

Sponsor: Rongjie Tao | Conditions: Brain Metastases | Phase 2 | Status: UNKNOWN